OBJECTIVES: Liver cirrhosis increases mortality and morbidity following cardiac surgery. This study evaluated the results of cardiac surgery in cirrhotic patients and the relevance of EuroSCORE, Child-Turcotte-Pugh (CTP) class and model for end-stage liver disease (MELD) score in terms of prediction of surgical mortality and survival.
INTRODUCTION
Liver cirrhosis is a potentially lethal disease, with life expectancy decreased by 40% compared with that of the same-aged general population [1] . In cardiac surgery, liver cirrhosis increases perioperative morbidity and mortality for a variety of reasons. First, vulnerability to bacterial infection is increased, which is related to the severity of liver dysfunction, leading to abnormalities of the defense mechanisms [2] . Second, the liver plays an important role in the clotting process, and acute and chronic liver diseases are commonly linked with coagulation disorders. Furthermore, portal hypertension may lead to congestive splenomegaly with trapping of platelets, leading to thrombocytopenia, and these haemostatic disorders can cause postoperative bleeding [3] .
The paucity of reports in the literature makes it difficult to determine the indications for surgery and the management of patients with hepatic cirrhosis [4] . In clinical practice, distinguishing patients who might benefit from cardiac surgery from those in whom perioperative risk exceeds benefit is problematic. It is, therefore, important to use predictive scores preoperatively in order to assess individual risk for each patient.
Although specific scores (e.g. EuroSCORE) exist to assess the risk of operative mortality in cardiac surgery, liver disease has not been included in established cardiac surgical risk models. In this population, specific scores are needed to evaluate operative risk.
Child-Turcotte-Pugh (CTP) class was originally designed to predict results after surgery for portal hypertension in patients with cirrhosis [5] . It is also used to predict operative mortality in cirrhotic patients after general surgery. The model for end-stage liver disease (MELD) score has been used to prioritize organ allocation in patients awaiting liver transplant. This objective score has been shown to reflect the 90-day mortality in patients with cirrhosis [6] . Nevertheless, use of the MELD score and CTP class to predict operative results in cirrhotic patients undergoing cardiac surgery remains limited.
The purpose of our study was to evaluate the results of cardiac surgery in cirrhotic patients, to find predictors of outcomes and to assess the relevance of EuroSCORE, CTP class and the MELD score in terms of prediction of surgical morbidity, mortality and survival.
MATERIAL AND METHODS
We conducted a retrospective analysis of our records and selected all patients with hepatic cirrhosis who underwent cardiac surgery with or without extracorporeal circulation between January 1996 and January 2010 in the Department of Cardiovascular Surgery at CHU Nancy, France. Patients were considered to have cirrhosis if the diagnosis had been made by a hepatogastroenterologist on the basis of a liver biopsy, or a combination of imaging (ultrasound scan or magnetic resonance) and biological examination.
Data collection
Medical records were reviewed in order to collect preoperative and perioperative data. Follow-up data were collected from attending family doctors, patients and their families, and in cases of non-responders, from the administrative authorities to confirm survival.
In our department, the EuroSCORE is calculated preoperatively. For this study, it was recalculated (by the first author) using the EuroSCORE Web site (www.euroscore.org). In cases of discrepancy, the score was recalculated again to eliminate miscalculation.
CTP class was extracted from medical files in our hepatogastroenterology department. It was calculated using the following variables: severity of hepatic encephalopathy (grades 1-3), ascites (absent, mild, moderate), total bilirubin (mg/dl), serum albumin (mg/dl) and prothrombin time (s). CTP classification was based on the resulting score: A, 5-6; B, 7-9; C, 10-15 [5] .
The MELD score was calculated twice (by the first and second authors), using the Web site www.mayoclinic.org/meld and was based on the formula 3.8 × log(e) (bilirubin mg/dl) + 11.2 × log(e) (INR) + 9.6 log(e) (creatinine mg/dl).
Operative mortality was defined as death occurring in the first 30 postoperative days or during the same hospital stay. Standard EuroSCORE definitions of each risk factor and the outcome were used (www.euroscore.org). Postoperative renal failure was defined as an increase in serum creatinine to 2.0 mg/dl, an increase to twice the preoperative baseline level or a new requirement for dialysis. Postoperative infection was defined as a deep sternal wound infection, sepsis or any pulmonary infection proved by radiography or culture. A deep sternal wound infection was considered when an organism was cultured from the mediastinal tissue or fluid, when there was visual evidence of mediastinitis, or when chest instability was present. A superficial wound infection was defined as an infection that only involved skin or subcutaneous tissue. Prior to statistical analysis, preoperative risk factors of relevance to outcomes were identified (Table 1) .
Statistical analysis
Statistical analysis was performed using STATA ® 11 software. Categorical variables were expressed as percentages. The χ 2 -test was used to evaluate univariate categorical data when the minimum number of observations in a category was >5; otherwise, Fisher's exact test was used. Continuous variables were expressed as mean ± standard deviation. Student's t-test was used to analyse continuous variables that had a normal distribution, and the Wilcoxon rank-sum test was used for variables that had a non-parametric distribution. For 3 × 2 contingency tables, where the number of subjects in each group was small, the χ 2 -test for trend was used.
Variables identified by univariate analysis with a P-value <0.05 were added to a multivariate logistic regression model. We performed exact logistic regression modelling, which replaces the standard logistic regression for analysing small, skewed or sparse data sets. Model discrimination was evaluated using the area under the receiver operating characteristic (ROC) curve. By applying the ROC curves, we established a MELD cut-off of 15 to predict operative mortality. Survival analysis was conducted according to the Kaplan-Meier method, and corresponding curves were built. Curves were compared using the log-rank statistic.
RESULTS
Between January 1996 and January 2010, 34 patients with liver cirrhosis underwent cardiac surgery with (n = 33, 97%) or without (n = 1, 3%) cardiopulmonary bypass (CPB). Thirteen patients (38%) underwent coronary artery bypass graft (CABG), 11 (32%) aortic valve replacement, 3 (9%) mitral valve replacement, 4 (12%) aortic and mitral valve replacement, 1 (3%) mitral valve replacement and tricuspid plasty, 1 (3%) aortic root replacement and 1 (3%) atrial septal defect closure. Mean age at surgery was 65 ± 11 years, and 76% subjects were males. Two patients (6%) underwent emergency surgery. Six were operated on for endocarditis (n = 17, 6%). In three patients (9%), redo surgery was performed. Mechanical valves were used in 12 patients (60%), and biological valves in 8 (40%). Patient demographics can be seen in Table 1 . For those who underwent CABG, bypass was realized with one mammary artery for the revascularization of the left anterior descending artery and with venous grafts for the other arteries.
The following aetiologies of cirrhosis were identified: alcohol abuse (n = 20, 58%), viral hepatitis (n = 7, 21%), viral hepatitis plus alcohol abuse (n = 4, 12%), primary biliary cirrhosis (n = 2, 6%) and haemochromatosis (n = 1, 3%). At admission to hospital, 22 patients (65%) were in CTP class A, 10 (29%) in class B and 2 in class C (6%). The mean preoperative MELD score was 12 ± 3.5. Preoperative risk factors are summarized in Table 2 . For the 33 patients undergoing cardiac surgery with CPB, the mean crossclamp time and CPB time were 70 ± 34 and 100 ± 66 min, respectively.
Operative morbidity and mortality
Mortality and morbidity rates are shown in Table 3 . The overall in-hospital mortality rate was 26% (n = 9). The cause of death included sepsis (n = 3, 9%), necrotic bowel ischaemia (n = 1, 3%), hepatic decompensation with multisystem organ failure (n = 4, 12%) and neurological complications (n = 1, 3%). Postoperative morbidities included respiratory failure ( prolonged ventilation > 72 h, n = 3, 9%), ischaemic or haemorrhagic gastrointestinal complications (n = 5, 15%), postoperative renal failure (n = 7, 21%), sepsis (n = 3, 9%), deep sternal infection (n = 2, 6%), superficial wound infection (n = 1, 3%) and reoperation for bleeding )  PRBC  86  63  100  Plasma  57  82  100  Platelets  52  82  100  Total  86  63  100 PRBC: packed red blood cells. (n = 1, 3%). Six patients (18%) needed reoperation for pericardial effusion. Eleven patients (32.3%) developed a postoperative infection, including two deep sternal wound infections. Postoperative mortality rates of patients with CTP class A cirrhosis, class B cirrhosis or class C cirrhosis were 18, 40 and 100%, respectively. The postoperative mortality rate of patients with a MELD score <15 was 20%. In those with MELD score ≥15, the postoperative mortality rate was 44.4% (P = 0.12).
The mean blood volume in the chest tube was 524 ± 317.9 ml in the first 24 h and 907 ± 622.8 ml in the first 48 h after surgery. No significant difference in bleeding was noted between CTP A, B and C, or between MELD <15 and ≥15 in the first 24 or 48 h after surgery (Fig. 1) . Postoperative thoracic drainage loss did not differ significantly between survivors and non-survivors. Twenty-four patients were transfused in the first 24 h postoperatively. Table 2 shows details of the different blood products used during the operation and the first 24 h postoperatively.
Aprotinine was used until 2008 (the protocol recommended 50% of the high dose or Hammersmith dose regime), and since 2008 we have used tranexamic acid (50 mg/kg, one dose each before and after CPB). The mean duration of mechanical ventilation was 30 ± 59 h, and the mean duration of the cardiac intensive care stay was 5.2 ± 5 days.
In univariate analysis, a preoperative history of cerebrovascular disease, the presence of ascites and the albumin concentration were all predictive of operative mortality (P = 0.07; Table 2 ). Multivariate exact logistic regression to test the contribution of the univariate risk predictors showed that low albumin concentrations were predictive of operative mortality (P = 0.02; Table 3 ).
Mid-term survival
Mid-term survival for all cirrhotic patients, including in-hospital mortality, was 63 ± 0.08% at 1 year and 40.2 ± 0.12% at 5 years ( Fig. 2A) . The 1-year survival, including hospital mortality, for a MELD score <15 and a MELD score ≥15 was 67.4 ± 0.09 and 55.6 ± 0.18%, respectively; 5-year survival was 54.2 ± 0.01 and 0% (P = 0.09), respectively (Fig. 2B) . The 1-year survival, including hospital mortality, for CTP class A and B was 76.7 ± 0.09 and 60 ± 15.4%, respectively; the 5-year survival was 60 ± 15.4 and 25 ± 0.19%. All patients with CTP class C died during the 30-day in-hospital period (Fig. 2C ).
Predictive value of EuroSCORE, CTP class and MELD score
The mean operative mortality predicted by the EuroSCORE was 7.2 ± 7.8%.
When evaluating the ability of the EuroSCORE, CTP class and the MELD score to predict the occurrence of operative mortality in cirrhotic patients undergoing surgical procedures, we found that the EuroSCORE is not discriminant, with an area under the curve (AUC) of 0.57 ± 0.15 (Fig. 3A) . CTP and MELD were found to perform better, but did not provide optimal discrimination; the AUC for MELD was 0.691 ± 0.110 and that for CTP was 0.658 ± 0.10 ( Fig. 3B and C) . No statistically significant difference was found between the AUCs for the MELD score or the AUCs for CTP class in these patients (P = 0.8; Fig. 3D ). 
DISCUSSION
In the present study, we analysed the in-hospital outcome and the mid-term survival of patients with liver cirrhosis who underwent cardiac surgery. We attempted to assess whether preoperative risk factors allow for the determination of operative mortality. We also assessed whether risk models, such as the EuroSCORE, CTP class and the MELD score, may be useful in predicting operative mortality.
Patients with cirrhosis are known to have high mortality and morbidity rates after abdominal surgery [7, 8] and the situation is similar in cardiac surgery. Mortality after cardiac surgery in cirrhotic patients is rarely attributable to impaired cardiac function, but is due to an increased incidence of infections, gastrointestinal complications and bleeding. It is empirically accepted that cardiac surgery is contraindicated in patients in an advanced state of cirrhosis [9] , but we need more data to support this assumption.
In our study, the overall hospital mortality was 26%. The role of preoperative evaluation in patients with cirrhosis is a fundamental one in the case of elective surgical procedures. In the case of urgent procedures, evaluation is more difficult. If patients are undergoing emergency surgery where there is no reasonable alternative, there is little time for any preoperative intervention that could potentially reduce operative mortality and complications. In the case of elective surgery, on the other hand, it is very important to take time to optimize and evaluate cirrhotic patients in collaboration with hepatologists, in order to determine the extent of hepatic dysfunction and to ameliorate the clinical preoperative situation. Preoperative optimization includes the correction of coagulopathy, ascites, hepatic encephalopathy and malnutrition. It has been shown that converting a patient from CTP C to CTP B preoperatively improves postoperative survival [10] .
Risk assessment and selection of patients
In our study, we confirmed that the EuroSCORE does not predict postoperative mortality in cirrhotic patients and therefore cannot be used to select patients (The AUC of the EuroScore in our study was not discriminant (0.57 ± 0.15)). Operative risk is underestimated by the EuroSCORE. Indeed, this cardiac surgical score does not include liver disease in its algorithm, who represent the major risk in these patients. We evaluated specific hepatic scores (CTP and MELD) in an attempt to estimate operative risk.
The mortality rate increased significantly according to CTP classification (class A, 18%; B, 40%; C, 100%), which is similar to previous reports [4, [11] [12] [13] [14] . Our study confirms that cardiac surgery can be performed safely, with no increased risk, in patients in CTP class A, who demonstrated an acceptable operative mortality (18%) and mid-term survival (5-year actuarial survival: 60 ± 15.4%).
All patients in CTP C died during the 30-day in-hospital period. However, the number of patients in CTP C in our study was less. Thielmann et al. [15] reported a 100% operative mortality for patients in CTP C (n = 4). Filsoufi et al. [11] reported a mortality rate of 67% for CTP C patients (n = 6).
As patients in CTP C are often considered to be at too high risk, there is generally less experience in managing them and they are often not referred for cardiac surgery. This may explain why literature on this subject is limited. Our study supports the suggestion that cardiac intervention in patients in CTP C is associated with both high morbidity and mortality. Thus, cardiac surgery in this patient group is unacceptable. A potential therapeutic approach could be combined orthotopic liver transplantation and cardiac surgery. However, there have been few publications to date on this treatment strategy, and more research is further needed. In cases of advanced cirrhosis (CTP C), (Fig. 2A) .Mid-term survival according to MELD scores <15 or ≥15 (Fig. 2B ) and CTP class (Fig. 2C) and long-term survival according to MELD scores <15 or ≥15 and CTP class.
ADULT CARDIAC
Problems remain for patients in CTP class B. The operative mortality is high (in our study, 40%) and the mortality rates reported in the literature range from 0 to 80% [4, 9, [12] [13] [14] . The decision to perform cardiac surgery in this population is difficult, as the patient group tends to be heterogeneous. A more discriminatory test is needed, and the use of the MELD score could help in decision-making. Compared with CTP class, the MELD score has the advantage of relying entirely on objective parameters for its calculation. It does not require subjective evaluation of the degree of ascites and encephalopathy. In addition, the MELD score has an ample range of potential numeric values (6-40 for MELD, compared with 5-15 for CTP), thereby theoretically facilitating enhanced discrimination between patients with different degrees of hepatic dysfunction [16] . Thielman et al. [15] identified a cut-off value of 13.5 for the MELD score. Similar results were found by Suman et al. [17] , who used a cut-off value for MELD of 15. However, this value was not significant (P = 0.06) in predicting operative mortality, possibly because of the less number of patients. The performance of MELD was better than EuroSCORE, but not optimal, with AUCs of 0.7. The less number of patients probably explains the lack of discriminatory power.
Risk and management of infections
Similar to earlier reports, 11 of the 32 patients (34%) experienced infection after cardiac surgery. This increased prevalence of infectious complications after cardiac surgery in cirrhotic patients can be explained by the presence of various dysfunctions in the mechanisms of defense against infection, including a decreased reticuloendothelial system and granulocyte function, decreased complement concentrations and changes in cellmediated immunity. Modifications to the digestive flora and the intestinal barrier may also contribute to the pathophysiology of bacterial infections during cirrhosis. Additionally, patients with cirrhosis often have other associated disorders such as malnutrition and hypoalbuminaemia, which can exacerbate pre-existing immune dysfunction. To prevent postoperative infection, no specific antibiotic prophylaxis is recommended. Our standard regime includes cefamandol (1.5 g preoperatively, 0.75 g was added to the prime solution and 0.75 g every 2 h during the operation). Bacterial translocation is the key to postoperative infectious complications in cirrhotic patients, but digestive tract decontamination has not been shown to be beneficial [18] . In this population, our policy is to improve nutritional status and to avoid the use of the bilateral mammary artery in an attempt to reduce the risk of mediastinitis.
Management of coagulopathy
Bleeding after surgery is an important and common complication of liver cirrhosis. Bleeding is generally believed to result from a haemostatic defect, but in reality, changes occur in both the pro-and anti-haemostatic pathways, so that the net result is often balanced. Nonetheless, haemorrhagic risk is increased in cirrhotic patients due to major alterations in the haemostatic pathway, including alterations in platelet, endothelial dysfunction, clotting factors, hyperfibrinolysis and dysfibrinogenaemia [19] . In our study, however, we found no bleeding problems. Only one patient underwent surgical re-exploration for mediastinal bleeding, and the mean chest output was acceptable in the first 24 h (524 ± 317.9 ml). We administered early, and almost routinely, blood products including packed red cells, fresh frozen plasma, platelets and cryoprecipitate for the correction of haemostatic disorders. This approach, more than likely, explains the low bleeding rate observed in our study and the fact that no differences in bleeding rates were seen between CTP A, B and C, or between a MELD score <15 and ≥15.
The prediction of bleeding is problematic. Conventional tests of coagulation such as PT-INR are helpful in terms of prognosis, but are not predictors of bleeding [19] . Specific tests, such as the blood thromboelastogram, which reflects the quantity of factors, clot time formation and indirectly fibrinogen levels, can be helpful.
Oral or parenteral vitamin K should be administered preoperatively if a deficiency is suspected, for example, in alcoholics, those malnourished, or those on long-term parenteral nutrition or antibiotic treatment.
Tranexamic acid is an antifibrinolytic agent that can be helpful for the treatment of hyperfibrinolysis; however, no controlled clinical studies have yet proven its efficacy [19] . The use of blood products ( platelets, plasma and cryoprecipitate) is helpful for the control of haemorrhage. Platelet transfusions are important for primary haemostasis, but are also the major source of phospholipids that participate in the generation of the thrombin burst [19] . Use of factor rFVIIa could be useful in cirrhotic patients if bleeding persists [19] .
To reduce bleeding complications during follow-up and when management of anticoagulation is difficult, we recommend the use of biological valves, regardless of the age of the patient.
Malnutrition
Low albumin is a risk factor for operative mortality in these patients as it reflects the extent of the cirrhosis. In both noncardiac and cardiac surgery, the albumin concentration is a predictor of postoperative mortality and morbidity, reflecting nutritional status [20] [21] [22] . In this population, it is important to use supplemental enteral nutrition to increase the nutritional status.
Operative management
In patients with chronic liver disease, CPB is associated with a high mortality. One patient in CTP class B underwent off-pump coronary artery bypass (OPCAB) with an uneventful postoperative course. Hayashida et al. [12] found that patients who underwent surgery without CPB had significantly less morbidity and mortality. Filsoufi et al. [11] reported that no mortality occurred in patients who underwent OPCAB. Marui et al. [23] found no difference between on-pump, off-pump and percutaneous revascularization, but this study did not evaluate the severity of the liver disease.
The literature on this subject is limited, however, and more investigations are necessary to confirm whether OPCAB is more beneficial in patients with advanced cirrhosis, and whether it could serve as an alternative to cardiac surgery utilizing CPB.
Weaknesses in our study include the fact that the number of patients was limited, as well as the retrospective design.
Moreover, the group was heterogeneous. However, to date, this study remains one of the largest series of cirrhotic patients undergoing cardiac surgery reported in the literature. Nevertheless, further studies with large numbers of patients are needed.
CONCLUSION
Cardiac surgery can be performed safely in CTP class A patients. In those with advanced cirrhosis (CTP class C), cardiac surgery is too hazardous, and an alternative treatment must be considered. In patients in CTP class B, the MELD score may help in deciding whether surgical intervention is reasonable. However, large studies are needed to definitely evaluate this test.
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